Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000263679 | SCV000413714 | uncertain significance | Optic Atrophy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000304484 | SCV000413715 | uncertain significance | 3-Methylglutaconic aciduria type 3 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000263679 | SCV000413720 | uncertain significance | Optic Atrophy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000304484 | SCV000413721 | uncertain significance | 3-Methylglutaconic aciduria type 3 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004694435 | SCV005194682 | uncertain significance | not provided | criteria provided, single submitter | not provided |